Good call. Only thing was I had already cut the MSO model revenue from 1,000,000,000 to 500,000,000. Now I have to cut it another 50%. Having said that, between that 250 million and the E 37 numerous indications, Olaregen and Altucell purchases. Not counting all the other stuff. We should be worth at least 1.5-2 B with only 70 m shares. All this for around $2!